Search News
| 19.35 Delayed Data As of Apr 20 |  -0.50 / -2.52%Today’s Change | 11.93 Today|||52-Week Range 24.85 | +46.04% Year-to-Date |
| Previous close | 19.85 |
| Today’s open | 19.80 |
| Day’s range | 19.00 - 19.95 |
| Volume | 527,492 |
| Average volume (3 months) | 1,078,378 |
| Market cap | $698.8M |
| Earnings growth (last year) | -8,057.14% |
| Earnings growth (this year) | -58.28% |
| Earnings growth (next 5 years) | +4.40% |
| Revenue growth (last year) | +14.63% |
| P/E ratio | NM |
| Price/Sales | 0.76 |
| Price/Book | 0.88 |
| Today’s change | Today’s % change | |
|---|---|---|
| BOLDAudentes Therapeutic... | -0.43 | -1.10% |
| ANABAnaptysBio Inc | +0.80 | +0.88% |
| MCRBSeres Therapeutics I... | -0.17 | -2.15% |
| ANIPANI Pharmaceuticals ... | -0.67 | -1.10% |
| Next reporting date | May 3, 2018 |
| EPS forecast (this quarter) | $0.87 |
| Annual revenue (last year) | $609.9M |
| Annual profit (last year) | -$199.2M |
| Net profit margin | -32.66% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William K. Heiden |
Chief Financial Officer, Treasurer & Senior VP Edward H. Myles |
Corporate headquarters Waltham, Massachusetts |
